ProfileGDS4516 / 207718_x_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 38% 35% 34% 36% 33% 30% 34% 35% 33% 39% 33% 32% 37% 35% 36% 40% 38% 33% 36% 39% 46% 29% 45% 28% 34% 38% 33% 38% 28% 32% 35% 34% 37% 33% 31% 30% 31% 35% 34% 37% 38% 38% 42% 42% 35% 37% 33% 34% 36% 31% 37% 39% 36% 33% 36% 41% 21% 30% 33% 41% 37% 34% 35% 33% 36% 29% 29% 31% 21% 23% 26% 35% 34% 38% 31% 31% 35% 36% 42% 32% 47% 30% 30% 34% 37% 26% 42% 35% 33% 41% 32% 37% 28% 38% 35% 35% 36% 32% 38% 43% 43% 34% 26% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]4.7653838
GSM537345patient 119, cancer, LCM [OPG study]4.5367735
GSM537355patient 138, cancer, LCM [OPG study]4.5385334
GSM537366patient 154, cancer, LCM [OPG study]4.6160736
GSM537370patient 022, cancer, LCM [OPG study]4.4262233
GSM537380patient 037, cancer, LCM [OPG study]4.3442730
GSM537392patient 077, cancer, LCM [OPG study]4.4888634
GSM537415patient 032, cancer, LCM [OPG study]4.515535
GSM537417patient 042, cancer, LCM [OPG study]4.5971833
GSM537422patient 059, cancer, LCM [OPG study]4.7840839
GSM537423patient 064, cancer, LCM [OPG study]4.4683333
GSM537427patient 084, cancer, LCM [OPG study]4.3625532
GSM537430patient 090, cancer, LCM [OPG study]4.6902337
GSM537336patient 107, cancer, LCM [OPG study]4.5445235
GSM537337patient 108, cancer, LCM [OPG study]4.5853336
GSM537348patient 124, cancer, LCM [OPG study]4.8538640
GSM537349patient 125, cancer, LCM [OPG study]4.7188138
GSM537356patient 139, cancer, LCM [OPG study]4.4831233
GSM537361patient 147, cancer, LCM [OPG study]4.65436
GSM537374patient 026, cancer, LCM [OPG study]4.8009539
GSM537377patient 033, cancer, LCM [OPG study]5.2175746
GSM537378patient 034, cancer, LCM [OPG study]4.282129
GSM537379patient 036, cancer, LCM [OPG study]5.1594145
GSM537383patient 046, cancer, LCM [OPG study]4.233128
GSM537388patient 063, cancer, LCM [OPG study]4.5552934
GSM537395patient 082, cancer, LCM [OPG study]4.6781938
GSM537400patient 099, cancer, LCM [OPG study]4.4585333
GSM537404patient 129, cancer, LCM [OPG study]4.7785738
GSM537409patient 141, cancer, LCM [OPG study]4.2021428
GSM537418patient 044, cancer, LCM [OPG study]4.3651932
GSM537425patient 070, cancer, LCM [OPG study]4.587835
GSM537333patient 102, cancer, LCM [OPG study]4.5441834
GSM537342patient 116, cancer, LCM [OPG study]4.6567537
GSM537347patient 123, cancer, LCM [OPG study]4.5430733
GSM537350patient 127, cancer, LCM [OPG study]4.4093231
GSM537362patient 148, cancer, LCM [OPG study]4.3847230
GSM537363patient 150, cancer, LCM [OPG study]4.3731831
GSM537368patient 156, cancer, LCM [OPG study]4.5687235
GSM537376patient 031, cancer, LCM [OPG study]4.5766334
GSM537381patient 038, cancer, LCM [OPG study]4.6557937
GSM537386patient 057, cancer, LCM [OPG study]4.7735638
GSM537398patient 094, cancer, LCM [OPG study]4.7188138
GSM537402patient 109, cancer, LCM [OPG study]4.9372642
GSM537405patient 130, cancer, LCM [OPG study]4.9904542
GSM537371patient 023, cancer, LCM [OPG study]4.5857235
GSM537421patient 055, cancer, LCM [OPG study]4.6764837
GSM537424patient 065, cancer, LCM [OPG study]4.4724133
GSM537432patient 097, cancer, LCM [OPG study]4.5178434
GSM537331patient 100, cancer, LCM [OPG study]4.6475836
GSM537332patient 101, cancer, LCM [OPG study]4.3458431
GSM537334patient 103, cancer, LCM [OPG study]4.6898937
GSM537338patient 110, cancer, LCM [OPG study]4.7917239
GSM537353patient 135, cancer, LCM [OPG study]4.6166136
GSM537357patient 142, cancer, LCM [OPG study]4.4171733
GSM537358patient 143, cancer, LCM [OPG study]4.6169736
GSM537375patient 030, cancer, LCM [OPG study]4.9252341
GSM537389patient 068, cancer, LCM [OPG study]3.8506721
GSM537390patient 072, cancer, LCM [OPG study]4.3079130
GSM537393patient 078, cancer, LCM [OPG study]4.4476633
GSM537399patient 095, cancer, LCM [OPG study]4.9213841
GSM537407patient 133, cancer, LCM [OPG study]4.7541637
GSM537408patient 140, cancer, LCM [OPG study]4.5326534
GSM537428patient 086, cancer, LCM [OPG study]4.5821735
GSM537354patient 136, cancer, LCM [OPG study]4.4613833
GSM537410patient 146, cancer, LCM [OPG study]4.6231336
GSM537413patient 027, cancer, LCM [OPG study]4.2203729
GSM537396patient 083, cancer, LCM [OPG study]4.2886229
GSM537397patient 088, cancer, LCM [OPG study]4.3750131
GSM537330patient 006, cancer, LCM [OPG study]3.9536721
GSM537369patient 015, cancer, LCM [OPG study]4.0205923
GSM537373patient 025, cancer, LCM [OPG study]4.1627926
GSM537401patient 106, cancer, LCM [OPG study]4.5901935
GSM537343patient 117, cancer, LCM [OPG study]4.5411734
GSM537367patient 155, cancer, LCM [OPG study]4.7794538
GSM537382patient 041, cancer, LCM [OPG study]4.4036831
GSM537385patient 053, cancer, LCM [OPG study]4.3898831
GSM537391patient 073, cancer, LCM [OPG study]4.5566535
GSM537419patient 045, cancer, LCM [OPG study]4.6442436
GSM537420patient 052, cancer, LCM [OPG study]5.017242
GSM537429patient 089, cancer, LCM [OPG study]4.3427432
GSM537431patient 096, cancer, LCM [OPG study]5.29147
GSM537387patient 061, cancer, LCM [OPG study]4.3207330
GSM537414patient 028, cancer, LCM [OPG study]4.3012130
GSM537433patient 098, cancer, LCM [OPG study]4.5574534
GSM537335patient 104, cancer, LCM [OPG study]4.6392637
GSM537339patient 111, cancer, LCM [OPG study]4.0994626
GSM537340patient 113, cancer, LCM [OPG study]4.9520742
GSM537344patient 118, cancer, LCM [OPG study]4.5648335
GSM537346patient 011, cancer, LCM [OPG study]4.4612133
GSM537351patient 128, cancer, LCM [OPG study]4.9073841
GSM537352patient 134, cancer, LCM [OPG study]4.3860932
GSM537359patient 144, cancer, LCM [OPG study]4.7476337
GSM537360patient 145, cancer, LCM [OPG study]4.2338828
GSM537364patient 152, cancer, LCM [OPG study]4.7400338
GSM537365patient 153, cancer, LCM [OPG study]4.6080735
GSM537372patient 024, cancer, LCM [OPG study]4.5974735
GSM537384patient 048, cancer, LCM [OPG study]4.636136
GSM537394patient 081, cancer, LCM [OPG study]4.4380832
GSM537403patient 121, cancer, LCM [OPG study]4.7748338
GSM537406patient 131, cancer, LCM [OPG study]5.0120943
GSM537411patient 149, cancer, LCM [OPG study]5.0629343
GSM537412patient 019, cancer, LCM [OPG study]4.5439134
GSM537416patient 035, cancer, LCM [OPG study]4.0930926
GSM537426patient 079, cancer, LCM [OPG study]4.5134535